Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.
about
Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.Nanomedicines for dysfunctional macrophage-associated diseases.Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines.
P2860
Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lipid-based nanosystems for CD ...... ng challenges and unmet needs.
@en
type
label
Lipid-based nanosystems for CD ...... ng challenges and unmet needs.
@en
prefLabel
Lipid-based nanosystems for CD ...... ng challenges and unmet needs.
@en
P2093
P2860
P50
P356
P1433
P1476
Lipid-based nanosystems for CD ...... ing challenges and unmet needs
@en
P2093
Elias Fattal
Hervé Hillaireau
Juliette Vergnaud
Thais Leite Nascimento
P2860
P304
P356
10.2217/NNM-2016-5000
P577
2016-07-07T00:00:00Z